UK Universities Develop Revolutionary Stem Cell Therapy for Hirschsprung Disease
核心洞察
Scientists from the University of Sheffield, UCL Great Ormond Street Institute, and Queen's University Belfast are developing a stem cell therapy to provide a permanent cure for Hirschsprung disease (搜索), a rare condition affecting newborns' digestive systems.
The £2.7 million UKRI-funded project has created a method to grow missing enteric nervous system (搜索) nerves from human stem cells in just six days, nearly twice as fast as existing methods.
The lab-grown cells have demonstrated effectiveness in restoring gut function in patient tissue samples and are "off-the-shelf" ready, meaning they can be frozen and transported to hospitals across the UK.
Scientists are developing a revolutionary stem cell therapy to treat Hirschsprung disease (搜索), a rare and life-threatening condition that leaves newborn babies unable to digest food without invasive surgery. The groundbreaking research represents a collaboration between the University of Sheffield, UCL Great Ormond Street Institute of Child Health (搜索), and Queen's University Belfast, bringing together world-leading experts in stem cell biology, gastrointestinal tract physiology, statistics and health economics.
The £2.7 million UKRI-funded project aims to provide a permanent cure for children born without a functional "second brain" in their digestive tract. For children with Hirschsprung disease (搜索), digesting food poses a life-threatening challenge because they are born without the vital network of nerves in the bowel known as the enteric nervous system (搜索).
Breakthrough in Cell Production Speed
The research team, led by Dr. Anestis Tsakiridis from the University of Sheffield, has developed a method to 'grow' missing nerves from human stem cells. This new Sheffield-developed technique can produce the cells needed to build vital nerves in just six days - almost twice as fast as existing methods.
"This grant provides us with a unique opportunity to take our stem cell therapy for this devastating disease one step closer to the clinic," said Dr. Tsakiridis. "We are incredibly grateful to the MRC for supporting this work, which allows us to move our cell production method out of the lab and toward real-world application."
Clinical Validation and Integration
The team has demonstrated that their lab-grown cells are not only effective at restoring gut function in patient tissue samples but are also "off-the-shelf" ready. This means the cells can be frozen and safely transported, a vital step in ensuring the therapy can be delivered to patients in hospitals across the UK and beyond.
The clinical team at UCL Great Ormond Street Institute of Child Health (搜索), led by Dr. Conor McCann, has already shown that these cells can successfully integrate into human tissue and restore the rhythmic contractions necessary for a healthy gut. This partnership ensures that the laboratory science is grounded in real-world clinical need and guided by the lived experiences of families affected by the condition.
"The award of this funding will provide a step change in allowing us to bring our stem cell-based treatment closer to the clinic," said Dr. McCann. "We hope that by bringing together the expertise of different groups across the UK we can drive this project towards a clinical trial that will hopefully benefit children with Hirschsprung disease (搜索) and their families."
Current Treatment Limitations
Currently, treatments for Hirschsprung disease (搜索) involve surgically removing the non-functional section of the gut, but many patients continue to suffer from life-long infections and bowel dysfunction. The new stem cell approach offers the potential for a one-time treatment that could eliminate these ongoing complications.
Economic and Clinical Impact
To ensure the therapy can be integrated into the NHS, experts from UCL and Queen's University Belfast will develop the health economic framework for the project. Early modeling suggests that a one-time cell therapy could be a highly cost-effective alternative to the long-term burden of repeat surgeries and specialized care currently required by patients.
The research team will also be working closely with families affected by Hirschsprung disease (搜索) and the charity Guts UK (搜索) to ensure they prepare for the next phase of the project, which will focus on safety testing ahead of first in-human clinical trials.
Future Applications
While the initial focus is on Hirschsprung disease (搜索), the researchers believe this technology could eventually be adapted to treat other debilitating gut disorders such as achalasia (搜索) and gastroparesis (搜索) - potentially reversing permanent damage once thought untreatable.